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1.1 Structure and basic functions of the pancreas 
The pancreas is made up of exocrine and endocrine parts. The exocrine pancreas 
secretes approximately 1.5-2 liters of isotonic fluid per day, which is rich in HCO$% and 
contains digestive enzymes. The exocrine pancreas consists of two main cell types: acinar 
cells (responsible for the production of digestive enzymes) and ductal cells (responsible for 
bicarbonate and fluid secretion), the former cells constitute the majority of glandular tissue. 
The ductal cells form a complex tubular network that runs through the entire gland and 
unites in an outlet duct (Wirsungianus). 
1.2 Ductal bicarbonate secretion 
The primary role of pancreatic ductal cells is the secretion of HCO$%. The first step 
in the secretion of HCO$% is its uptake from the extracellular space. This process occurs 
through the basolateral membrane via the Na+/HCO$% cotransporter, or by diffusion of CO2, 
which is then converted to H2CO3 by carbonic anhydrase. The resulting protons are released 
from the cell by Na+/H+ exchangers or H+ pumps. Intracellular	HCO$% derived from H2CO3 
is secreted through transporters. This is followed by the second step of HCO$% secretion: HCO$% exits ductal cells via cystic fibrosis transmembrane conductance regulator (CFTR) 
and solute carrier anion exchangers (SLC26A3, or down-regulated in adenoma, DRA; or 
SLC26A6, putative anion transporter-1, PAT-1) and is secreted into the luminal space. 
In contrast with the well-understood role of digestive enzymes, the functions and 
processes of pancreatic electrolyte secretion have not yet been clearly described, although 
it surely facilitates the transport of zymogens to the small intestine and contributes to the 
neutralization of stomach acid in order to provide optimal pH for digestive enzymes in the 
duodenum. This is significant because maintaining a neutral or alkaline luminal pH is 
crucial for the membrane dynamics of acinar cells and, consequently, for the exocytosis of 
zymogen granules. Previous studies have shown that lower extracellular pH enhances 
secretagogue-induced zymogen activation in acinar cells. Recent studies have also shown, 
as a result of the Pancreatic Research Group in Szeged, that proper HCO$% secretion is 
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essential to prevent autoactivation of trypsin in the ductal tree. Moreover, trypsin itself can 
reduce apical proteinase-activated receptor-2 by activating CFTR-dependent HCO$% 
secretion in ductal cells, leading to further trypsin autoactivation. Thus, the reduction of 
ductal HCO$% secretion is of paramount importance in the preservation of intact pancreatic 
structure. 
1.2.1 The roles of CFTR and NHERF-1 in ductal secretion 
CFTR is expressed in the apical membrane of ductal cells, but it is absent in acinar 
cells. Its proper function is essential for pancreatic ductal HCO$% and fluid secretion. The 
importance of CFTR can be illustrated by cystic fibrosis, in which the lack of CFTR-
dependent fluid secretion has been shown to cause nearly complete glandular destruction 
at birth in 85% of patients. 
The intercalated and/or intralobular and interlobular ductal cells express CFTR (to 
varying degrees depending on the species) and are responsible for producing an isotonic, 
highly alkaline fluid with a 140 mM NaHCO3 content. However, the composition of the 
secretion may vary from species to species depending on the flow rate. At maximum 
velocity,	HCO$% concentration is about 140 mM in most species with the exception of rats 
and mice, where the maximum is about 70 mM.  
Na+/H+ exchanger regulatory factor-1 (NHERF-1), also known as Ezrin binding 
protein-50 (EBP50) is a cytosolic regulatory protein. The role of NHERF-1 in the pancreas 
is not yet well understood. However, deletion of NHERF-1 resulted in gross mislocalization 
of CFTR, causing marked reduction in pancreatic ductal fluid and bicarbonate secretion. 
1.2.2 Role of SLC26A3/A6 in ductal bicarbonate secretion 
SLC26A6 (putative anion transporter-1, PAT-1) was originally identified as a 
chloride transporter, but subsequent studies have shown that it functions as a 2HCO$%/1Cl- 
exchanger. Although some laboratories have examined the characteristics of HCO$% 
transport in intact pancreatic ducts isolated from SLC26a6 KO mice, further investigation 
is required to prove the role of SLC26 anion exchangers in ductal fluid and HCO$% secretion. 
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1.2.3 Role of aquaporins in ductal fluid secretion 
Aquaporins (AQPs) are small membrane proteins whose primary function is to help 
transport water molecules. Recent studies have highlighted their essential role in specific 
regulatory. To date, 13 AQP isoforms have been identified in mammals, and some show 
species-specific expression patterns in the pancreas. AQP1, -5, -8, and -12 are also present 
in the human pancreas. AQP1 is the first AQP described that is only permeable to water. 
The presence of AQP1 has been previously demonstrated in the apical and lateral plasma 
membranes of centrifugal cells and the apical and basolateral membranes of intercalary and 
intralobular ductal cells. AQP5 has been proven to be an aquaglyceroporin that aids in the 
transport of water along with glycerol, urea, and other small solutes. The expression of 
AQP5 was not detected in the centroacinar cells but only in the apical plasma membrane 
of the intercalated ducts. The colocalization of AQP1 and -5 with CFTR on the apical 
membrane of the ducts is of particular interest, confirming that the channels influence each 
other's function. 
1.3 Acute pancreatitis 
Acute pancreatitis (AP) is a sudden inflammation of the pancreas, the severity of 
which ranges from a mild to a severe, the latter of which sometimes has a fatal outcome. 
1.3.1 Clinical features 
1.3.1.1 Incidence and etiology 
The incidence of AP varies from country to country. In Western-type societies, it is 
most commonly 15-45/100 000 inhabitants/year, which is still slightly increasing. AP is 
one of the most common gastroenterological disorders requiring hospital admission. In fact, 
this means 200 000 hospital admissions in the US each year, costing the health care system 
$ 2-2.5 billion. 
Alcohol consumption and gallstones are responsible for the development and 
exacerbation of 70-80% of AP cases. However, several other etiological factors (e.g. drugs, 
hypertriglyceridemia, pancreatic- or ampulla of Vater tumor, trauma, various mumps-, 
H1N1-, Coxsackie virus, bacterial infections) are known. In 10-20% of cases, the cause 
cannot be identified. 
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1.3.1.2 Classification 
In 2011, the revised Atlanta-classification was created for the most accurate 
diagnosis, evaluation of severity, and classification of AP. On the basis of the development 
and duration of organ failure, mild, moderate and severe AP can be distinguished. 
Approximately 75-80% of cases are mild, 15-20% moderate, and about 10% are severe. In 
mild AP, no local or distant complications occur. Patients with mild AP have a mortality 
rate of less than 1%, it is around 5% with moderate pancreatitis, and 30% to 50% with 
severe AP. 
1.3.1.3 Clinical symptoms and treatment 
One of the most common symptoms of AP is abdominal pain, usually in the 
epigastrium, which radiates to the back.  The treatments given to the patient are mainly 
symptomatic, e.g. fluid replacement, nutrition, analgesia, reduction of pancreatic secretory 
function when needed, and antibiotics if an appropriate indication is present. Enteral 
nutrition can be either nasogastric (currently under investigation) or nasojejunal (classically 
accepted mode of nourishment). 
1.3.2  Pathomechanism 
The pathomechanism of the disease is not fully understood, and unfortunately, 
specific therapy is still unknown. Therefore, the search for new therapeutic targets, 
experimental, and clinical examination of inflammation is also vital for reducing the 
mortality of the disease. Thus, several theories are known about the pathomechanism of 
inflammation, the mechanisms of which have been learned from in vivo and in vitro 
experiments. All of which are likely to play a role in the development of human AP. 
In the pancreas, various aggressive and/or protective processes play a role in 
mediating the course of AP. The disease, initiated by various etiological factors, is likely 
to run on multiple parallel strands, which can eventually lead to inflammation of the 
pancreas and, in severe cases, cell death. These processes include: premature activation of 
trypsinogen, activation of nuclear factor kappa-B (NF-κB), early acinar mitochondrial 
damage, the role of white blood cells, oxidative stress, and inflammatory mediators. Heat 
shock proteins (e.g. HSP 72) and pancreatic ductal secretion are likely to be protective. 
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2 AIMS 
In this study, I had the following goals: 
• to investigate the role of NHERF-1 protein in acute experimental 
pancreatitis 
• to investigate the role of AQP1 channel in acute experimental pancreatitis. 
3 MATERIALS AND METHODS 
3.1 Ethical approval and animals 
Animal experiments were conducted in accordance with the Guide for the Care and 
Use of Laboratory Animals (2010/63/EU Directive). In addition, the experimental protocol 
was approved by the local Ethical Board of the University of Szeged, Hungary and also by 
the National Scientific Ethical Committee on Animal Experimentation (Budapest, 
Hungary). 
Mice were housed in a typical animal care facility in regular plastic cages on 
12:12 hour light-dark cycle at room temperature (23 ± 1 °C) and were allowed free access 
to standard laboratory chow for rodents and drinking water. All mice were genotyped prior 
to the experiments. Experiments were performed on litter-matched (12-16-week-old) wild-
type (WT), and NHERF-1 or AQP1 knock out (KO) male mice.  
3.2 Induction of acute pancreatitis 
3.2.1 Cerulein-induced pancreatitis  
AP was induced in mice by hourly (7 or 10 times) i.p. injections of cerulein 
(50 µg/kg per injection). Control mice were given PS (0.9 % NaCl) solution i.p. instead of 
cerulein. Two hours after the final injection, mice were euthanized by pentobarbital 
overdose (85 mg/kg i.p.). Mice were exsanguinated via the inferior vena cava (NHERF-1 
experiments) or via cardiac puncture (AQP1 experiments), and the pancreata were 
immediately removed. The pancreas was trimmed from fat and lymphatic tissue. 
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Approximately one-quarter of the pancreatic tissue was put into a 6 % neutral formaldehyde 
solution, and the other three quarters were dropped in liquid nitrogen and stored at -80 °C 
until use. The collected blood was centrifuged at 4 °C with 2500 RCF for 15 min and the 
serum was stored at -20 °C until use. 
3.2.2 Sodium-taurocholate-induced pancreatitis  
Na-taurocholate was administered intraductally (i.d.) as described previously by 
Perides et al. Briefly, anesthesia was carried out using i.p. administration of ketamine 
(125 mg/kg) and xylazine (12.5 mg/kg) cocktail. The duodenum was punctured with a 
0.4 mm diameter needle connected to a polyethylene tube after performing median 
laparotomy. Leakage of Na-taurocholate was prevented by temporary ligature of the 
biliopancreatic duct, while the proximal bile duct was temporarily occluded with a 
microvessel clip. 4 % Na-taurocholate or PS solution was infused with an infusion pump 
(10 μl/min) for 5 min. After the infusion, we removed the microvessel clip, the distal 
ligature, and also the injection needle. For a short time, the possibility of bleeding was 
monitored, and the abdominal wall and the skin were sewed. The body temperature of 
animals was monitored and was kept at 37 °C until they woke up. Mice were exsanguinated 
through the inferior vena cava 24 h after the i.d. injection. Thereafter, all procedures were 
carried out as described previously in the case of cerulein-induced pancreatitis. The only 
difference was that all of the pancreatic tissues were fixed in a 6 % neutral formaldehyde 
solution for histological quantification. 
3.3 Assays and histologic examination 
Amylase activity was measured with commercial colorimetric kit using a microplate 
reader at 405 nm. Acinar cell viability was determined by using the 0.4 % trypan-blue 
exclusion test. Pancreatic IL-1β concentrations were measured by ELISA. Pancreatic 
expression of HSP-72, IκB-α, and IκB-β contents were determined by Western-blot 
analysis. Myeloperoxidase (MPO) activity, as a marker of tissue leukocyte infiltration, was 
assessed by the method of Kuebler et al. 
Pancreatic injury was evaluated by semiquantitative grading of interstitial edema, 
leukocyte infiltration, necrosis, and in case of the Na-taurocholate model hemorrhage. The 
extent (%) of cell damage was confirmed by analysis with ImageJ software (NIH, Bethesda, 
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MD, USA). The fixed pancreatic tissue was embedded in paraffin blocks, cut into 3 µm 
thick sections, and stained for hematoxylin-eosin using standard techniques and viewed by 
light microscopy. A semiquantitative scoring system (0-3) was used in the case of AQP1 
experiments, as we described previously. Edema (0: none, 1: patchy interlobular; 2: diffuse 
interlobular; 3: diffuse interlobular, and interacinar), leukocytic infiltration (0: none; 1: 
patchy interlobular; 2: diffuse interlobular; 3: diffuse interlobular and interacinar). The rate 
of necrosis was expressed as a percentage of the total analyzed pancreatic area. 
3.4 Statistical analysis 
Statistical analysis was performed by SigmaPlot (Systat Software Inc., Chicago, IL, 
USA). Data are presented as means±SEM. Both parametric (one- or two-way analysis of 
variance (ANOVA) and non-parametric (Kruskal-Wallis) tests were used based on the 
normality of data distribution (analyzed by the Shapiro-Wilk test). Post-hoc analysis (either 
Dunn’s or Bonferroni’s test) was performed according to the recommendations made by 
SigmaPlot. c²-test was used to determine differences between groups in the proportion of 
mice who died. P<0.05 was accepted as statistically significant. 
4 RESULTS 
4.1 Cerulein-induced pancreatitis is more severe in NHERF-1-
knock-out mice 
To determine if the reduction of pancreatic secretion could influence the 
development of AP, WT or NHERF-1 KO mice were given 10 hourly i.p. injections of 
either PS (control) or supramaximal doses of cerulein. 
The control animals had normal pancreatic histology. I.p. injections of cerulein 
caused extensive pancreatic cell damage; the rates of necrosis, and apoptosis were markedly 
higher in the NHERF-1-KO vs. WT mice. However, no significant differences were 
observed in the extent of interstitial edema (2.0 ± 0.11 for WT vs. 2.2 ± 0.2 for KO) or 
leukocyte infiltration (1.72 ± 0.08 for WT vs. 1.95 ± 0.13 for KO, p=0.08) in 
cerulein-treated groups. 
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Serum amylase activities were significantly elevated in cerulein-treated vs. control 
WT and NHERF-1-KO mice. Importantly, amylase activity was significantly higher in the 
cerulein-treated NHERF-1-KO vs. WT mice. Pancreatic MPO activities were significantly 
increased in cerulein-treated vs. control groups, but they were not different in WT 
compared to KO mice exposed to cerulein. Pancreatic HSP-72 expression was significantly 
increased in cerulein-treated vs. control groups, and significant differences were also 
observed between cerulein-treated WT and NHERF-1-KO groups. 
Key events in the pathogenesis of AP include premature activation of pancreatic 
trypsinogen and the activation of the proinflammatory transcription factor NF-kB. To 
exclude any potential effects of NHERF-1 deletion on early trypsinogen and NF-kB 
activation (regulated by IĸBs), we measured pancreatic trypsin activity, and expression of 
IĸBs in mice injected i.p. with 1x50 μg/kg cerulein. Trypsin activity was increased by about 
4-fold 0.5 h after the injection of cerulein compared to the control group; however, there 
were no significant differences between WT and NHERF-1-KO mice. Also, with respect to 
IκB-α expression, there were no significant differences between WT and NHERF-1-KO 
animals in cerulein-treated groups. 
The expression of pancreatic IκB-β was significantly higher in NHERF-1-KO vs. 
WT control mice, and no differences were observed in cerulein-treated WT and 
NHERF-1-KO groups. These data demonstrate that the difference in AP severity between 
WT and NHERF-1-KO mice is independent of pancreatic trypsinogen and NF-κB 
activation. 
The expression of the proinflammatory cytokine IL-1β was significantly elevated 
in the pancreas of cerulein-treated vs. control WT and NHERF-1-KO mice, but there was 
no significant difference between the cerulein-treated WT vs. NHERF-1-KO mice. 
Of note, i.p. administration of 7x50 μg/kg cerulein in WT and NHERF-1-KO mice 
caused similar effects in the investigated histological and laboratory parameters, as shown 
for the higher cerulein dose. Overall, our results clearly demonstrate that the severity of 
cerulein-induced AP is lower in mice expressing NHERF-1. 
To exclude any possible deleterious effects of NHERF-1 deletion on 
cholecystokinin receptor function, we tested the sensitivity of acinar cells to cerulein. 
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Amylase secretion of acinar cells from WT and NHERF-1-KO animals showed no 
significant differences in response to cerulein stimulation. 
4.2 Intraductal administration of sodium-taurocholate causes 
more extensive acinar cell necrosis in NHERF-1-KO 
compared to wild-type mice 
We also investigated if NHERF-1-KO mice respond differently than WT mice when 
AP was induced by i.d. infusion of 4 % Na-taurocholate. Postoperative mortality after 
administration of Na-taurocholate in KO mice (2/14 animals) was not significantly 
different vs. WT animals (0/10). 
Intraductal infusion of PS caused no postoperative mortality, but mild pancreatic 
edema and inflammation were seen on histology without significant necrosis. The rate of 
leukocyte infiltration was significantly higher in the PS-treated NHERF-1-KO vs. WT 
mice. The infusion of 4 % Na-taurocholate into the pancreatic duct induced necrotizing AP 
in the head), but not in the tail of the pancreas (not shown). The latter finding is in accord 
with that of others. Therefore; only the pancreatic heads were used for histological analysis. 
Approximately 24 % of acinar cells were necrotic in WT and about 47 % in NHERF-1-KO 
mice. To summarize the histopathological changes in the various groups: significantly 
higher rates of leukocyte infiltration were detected in Na-taurocholate-treated vs. 
PS-treated WT groups. In contrast, there were no significant differences in leukocyte 
infiltration between the Na-taurocholate vs. PS-treated NHERF-1-KO groups, and 
Na-taurocholate-treated NHERF-1-KO vs. WT groups. 
Serum amylase activities were significantly higher in Na-taurocholate-treated vs. 
control WT and NHERF-1-KO groups, but there were no differences between 
Na-taurocholate-treated NHERF-1-KO and WT mice. We did not observe any significant 
differences in pancreatic MPO activity between WT and NHERF-1-KO mice after i.d. PS 
infusion. However, MPO activity was increased in Na-taurocholate-treated NHERF-1-KO 
vs. control mice and was even higher in the KO compared to the WT 
Na-taurocholate-treated mice. Pancreatic IL-1β expression was elevated in 
Na-taurocholate-treated WT and NHERF-1-KO mice vs. the control groups. However, 
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there were no significant differences in the levels of IL-1β of Na-taurocholate-treated WT 
and NHERF-1-KO animals. 
These data indicate that NHERF-1 expression reduces Na-taurocholate-induced 
pancreatic injury, but it does not necessarily influence other laboratory parameters of the 
disease. 
4.3 The severity of acute pancreatitis is aggravated in 
aquaporin-1 KO mice 
The pancreas had normal histology in both WT and AQP1 KO animals. In order to 
test the hypothesis that AQP1 may be involved in the pathomechanism of pancreatitis, we 
investigated the severity of cerulein-induced AP (10x50 μg/kg i.p.) in WT and AQP1 KO 
mice. I.p. injections of cerulein caused extensive cell damage both in the WT and KO 
animals. The extent of pancreatic necrosis was markedly greater in the AQP1 KO 
(25 ± 2.8 %) vs. WT mice (12.1 ± 3.2 %), whereas no significant differences were observed 
in the extent of edema and in the infiltration of inflammatory cells. 
The rate of pancreatic necrosis was more extensive in AQP1 KO vs. WT mice. 
Furthermore, serum amylase activities were significantly higher in KO (1605 ± 6 U/l) vs. 
WT mice (1285 ± 51 U/l) after the induction of AP. Overall, these results indicate that in 
the absence of AQP1 expression, the course of pancreatitis is more severe. 
5 DISCUSSION 
Until quite recently, the pathophysiological relevance of pancreatic ducts in AP has 
been neglected. It is commonly assumed that the primary target of all stressors is the acinar 
cells since they are damaged in all forms of AP. However, both clinical and experimental 
data suggest that pancreatic ductal cells may also have fundamental roles in the 
development of AP. Pancreatic fluid secretion is greatly increased at the initiation of AP. 
Also, in vitro administration of agents inducing AP such as ethanol, bile acids or viruses to 
pancreatic duct cells stimulate bicarbonate secretion. Our hypothesis was that ductal 
secretion serves to defend the pancreas by washing out toxic agents such as activated 
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digestive enzymes when NHERF-1 protein is present. If this ductal defense mechanism is 
insufficient, ductal secretion will be inhibited, and the harmful enzymes cannot leave the 
pancreas, so it leads to more severe AP. The beneficial effect of ductal fluid hypersecretion 
is indicated by the fact that secretin, a major mediator of pancreatic ductal secretion, has 
been shown to protect against cerulein-induced AP. Furthermore, there is accumulating 
evidence that impaired pancreatic fluid secretion plays a role in the pathomechanism of 
pancreatitis. 
In the present study, we investigated the roles of NHERF-1 and AQP1 (both of 
which have essential roles in pancreatic ductal secretion) in experimental AP. 
5.1 The role of NHERF-1 in acute experimental pancreatitis 
In the related article, we have demonstrated that NHERF-1 mRNA is highly 
expressed in mouse pancreatic ducts. Furthermore, the genetic deletion of NHERF-1 greatly 
reduced the expression of CFTR in the luminal ductal cell membrane and also decreased 
both in vitro and in vivo pancreatic bicarbonate and fluid secretion. This may contribute to 
significantly increased severity of acute necrotizing pancreatitis in NHERF-1-KO mice in 
two distinct models. Importantly, early acinar events associated with AP, like trypsinogen 
and NF-κB activation, were unaltered by genetic deletion of NHERF-1. However, late 
events such as apoptosis and necrosis were increased in the KO animals. Notably, the 
genetic deletion of NHERF-1 had no deleterious effects on functions of acinar and 
inflammatory cells, indicating that increased severity of the disease is precisely due to 
impaired ductal secretion. 
Our study does not differentiate between a loss of HCO$% and fluid secretion via 
CFTR or via a disruption between CFTR and other transporters involved in pancreatic 
bicarbonate and fluid secretion, such as solute carrier family 26 (SLC26) anion exchangers. 
The reduced expression of CFTR in the apical membrane in NHERF-1-KO pancreatic ducts 
thus will likely decrease the activities of PAT-1 and DRA. 
Several groups have shown that the binding of CFTR to NHERF may regulate 
CFTR activity. The unusually high expression of NHERF-1 and CFTR in pancreatic ducts 
is quite different from that found in the small intestine. These findings suggest to us that 
CFTR-NHERF-1 interaction may be crucial to pancreatic ductal secretion. 
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A striking finding of our study was that the severity of cerulein-induced acute 
necrotizing pancreatitis was significantly higher in animals lacking NHERF-1 (and thus 
reduced pancreatic ductal secretion), which suggests that normal ductal secretion in WT 
mice protects acinar cells against necrosis and apoptosis. This effect was independent of a 
change in cerulein sensitivity of acinar cells and shows that NHERF-1 expression is not 
necessary for cholecystokinin receptor function. As CFTR-KO mice exhibited constitutive 
overexpression of pancreatic proinflammatory mediators, this is not that surprising. To 
confirm that the effect of diminished secretion on AP severity was not specific to the 
cerulein-induced model, we also determined disease severity in the clinically more relevant 
Na-taurocholate model. Similar to the results observed in the cerulein-induced pancreatitis 
model, the degree of acinar cell damage in Na-taurocholate-induced AP was significantly 
greater in NHERF-1-KO versus WT mice. Our data indicate that KO animals may even be 
more sensitive to increased ductal pressure. 
Importantly, NHERF-1 expression did not influence the degree of the cell damage 
caused by high concentrations of cerulein or sodium taurocholate in isolated acini. These 
data indicate that the general deletion of NHERF-1 does not affect acinar damage caused 
by the latter agents. Therefore, it is likely that factors other than variations in the direct 
effects of cerulein or sodium taurocholate on acinar cells are responsible for the differences 
in AP severities of WT and NHERF-1-KO mice. 
5.2 The role of aquaporin-1 channel in acute experimental 
pancreatitis 
AQP1 is a water channel that is extensively expressed in pancreatic acinar and 
ductal cells that are involved in fluid secretion. Altered expression or localization of AQPs 
is associated with different gastrointestinal disorders, such as gastritis or diarrhea; 
therefore, many studies have been conducted to identify the specific role of particular AQP 
isoforms. Although AQP1 plays an essential role in pancreatic physiology, its function 
under pathological conditions is not known. In order to determine the role of the AQP1 
channel in AP, we used AQP1 KO mice. In the present study, we showed that the decreased 
expression of AQP1 in pancreatic ductal cells induces more severe pancreatitis in a 
cerulein-induced AP model. 
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There are contradictious data partly in contrast with previous observations 
demonstrating that defect in AQP1 expression cause only a small but not significant 
decrease in the rate of stimulated pancreatic fluid secretion. Although this discrepancy can 
be explained by the different methods used for the measurement of pancreatic fluid, 
nevertheless, other studies have found that decreased expression or function of AQP1 
dramatically reduces ductal fluid secretion. A direct interaction between AQPs and CFTR 
has also been observed in Sertoli cells. 
The deletion of AQP1 itself does not damage the pancreas and does not cause 
pancreatitis in mice, which might be due to the compensating effect of AQP5; however, it 
induces a more severe disease progression. The involvement of AQP1 in the 
pathophysiology of pancreatitis has already been raised previously. The importance of 
AQP1 in the exocrine pancreas has also been confirmed by the fact that this water channel 
is abundantly expressed in the zymogen granules of acinar cells and plays an essential role 
in zymogen swelling and probably secretion. All of these previous observations indicate 
that AQP1 has essential roles in both ductal and acinar functions and makes the pancreas 
more sensitive for AP. 
6 SUMMARY OF NEW FINDINGS 
1. NHERF-1 and AQP1 have profound effects on the outcome of acute 
pancreatitis. 
2. The severity of AP, particularly acinar necrosis and apoptosis was higher in 
NHERF-1 KO mice than in WT animals. 
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